IO Biotech to Present at Jefferies Global Healthcare Conference
IO Biotech, Inc. (IOBT)
Company Research
Source: GlobeNewswire
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, announced today that Mai-Britt Zocca, Ph.D., the company’s President and CEO, will be presenting, and both Dr. Zocca and Amy Sullivan, the company’s CFO, will be participating in one-on-one investor meetings at the Jefferies Global Healthcare Conference to be held June 4-6, 2024 in New York, NY. Presentation DetailsDate and Time: Wednesday, June 5, 2024, 7:30-7:55 AM ESTPresenter: Mai-Britt Zocca, Ph.D., President & CEOWebcast Link: https://wsw.com/webcast/jeff302/iobt/1842656 A webcast replay of the presentation will be available from the Investors section of the Company’s website at www.iobiotech.com for 90 days. About IO102-IO103 IO102-IO103 is an investigational off-the-shelf therapeutic cancer vaccine designed to kill both tumor cells and immune-suppress
Show less
Read more
Impact Snapshot
Event Time:
IOBT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IOBT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IOBT alerts
High impacting IO Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
IOBT
News
- Will IO Biotech (NASDAQ:IOBT) Spend Its Cash Wisely? [Yahoo! Finance]Yahoo! Finance
- IO Biotech, Inc. (NASDAQ: IOBT) had its price target raised by analysts at HC Wainwright from $8.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- IO Biotech Reports First Quarter 2024 Financial Results and Provides Business HighlightsGlobeNewswire
- IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewswire
- IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness [Yahoo! Finance]Yahoo! Finance
IOBT
Earnings
- 5/14/24 - Beat
IOBT
Sec Filings
- 6/11/24 - Form 8-K
- 6/7/24 - Form 4
- 6/7/24 - Form 4
- IOBT's page on the SEC website